Search the Cancer Center site

Home
About
About

Located in Worcester, Massachusetts, the UMass Cancer Center is committed to providing exceptional patient care, conducting cutting-edge research at the highest level, offering excellence in education and training, and serving as an educational resource and advocate for the Central Massachusetts community.
Patients
Patients

Expert Cancer Care in Central Massachusetts

We offer comprehensive cancer care for all childhood and adult cancers, combining state-of-the-art treatments with compassionate support for patients and their families.
Members
Clinicians
Research
Research

Cutting-Edge Cancer Research

We carry out front-line research in basic, translational, clinical and population-based discovery to find newer, better methods for the prevention, detection, diagnosis, and treatment of cancer.
Education
Education

World Class Medical and Scientific Education

The UMass Cancer Center is dedicated to training the next generation of cancer researchers, clinicians and physician-scientists.
Outreach
Michael Green Memorial
Michael Green Memorial

UMass Chan lost one of its greats when Michael R. Green, MD, PhD, passed away unexpectedly in February 2023. We've established these web pages in his memory so our visitors can take a few minutes, from time to time, to peruse and remember him.

Donate to the The Michael R. Green, MD, PhD, Award in Graduate Research:

Donate

Additional Resources

Patricia Minehart Miron, PhD

Professor, Department of Pathology, UMass Chan Medical School; Director of Cytogenetics at Quest Diagnostics (Marlborough)

Website

Page Menu

Patricia Minehart Miron, PhD

Research Focus - Improving and Developing Cytogenomic Assays for Oncology

Cytogenetic analysis for hematologic malignancies and a small number of solid tumors (such as lipoma/liposarcoma, Ewing and some other specific sarcomas, and neuroblastoma)
Full-service cytogenomics laboratory supporting UMass researchers and offering classical metaphase chromosome analysis, fluorescence in situ hybridization (FISH) assays and genomic chromosomal microarray to interrogate clinical specimens for genetic abnormalities

Representative Publication

Chun K, Wenger GD, Chaubey A, et al. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia. Cancer Genet. 2018;228-229:236-250.

Read Publication

More Publications